Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb;82(2):e5-e7.
doi: 10.1016/j.jinf.2020.09.027. Epub 2020 Sep 28.

The potential indicators for pulmonary fibrosis in survivors of severe COVID-19

Wenhui Huang  1 , Qingxia Wu  2 , Zhuozhi Chen  3 , Zhiyuan Xiong  4 , Kun Wang  5 , Jie Tian  6 , Shuixing Zhang  7
Affiliations
Comment

The potential indicators for pulmonary fibrosis in survivors of severe COVID-19

Wenhui Huang et al. J Infect. 2021 Feb.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The clinical course and the temporal changes of follow-up CT in fibrosis and non-fibrosis groups. (A) A series of indexes on admission showed significant difference between two groups. (B) Dynamic changes of inflammatory markers including neutrophils, lymphocytes, neutrophil-to-lymphocytes ratio, eosinophils, c-reactive protein, and lactate dehydrogenase showed distinct features between two groups. (C) Oxygen supply, ICU admission, complications and treatment during hospitalization were included for comparative analysis. ***, p<0.001; **, p<0.01; *, p<0.05. (D) Temporal changes in axial chest CT images of two survivors indicated the distinct evolutions of lung involvement. a) A 33-year-old male with critical pneumonia who undergone both ARDS and mechanical ventilation, discharged at March 5, 2020 with subtle linear opacities on follow-up CT. b) A 69-year-old male with critical pneumonia, undergone both ARDS and mechanical ventilation and discharged at March 1, 2020 with fibrotic pulmonary remodeling on follow-up CT. ARDS indicates acute distress respiratory syndrome.
See this image and copyright information in PMC

Comment on

References

    1. Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. - PMC - PubMed
    1. Mo X., Jian W., Su Z., Chen M., Peng H., Peng P. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6) - PMC - PubMed
    1. Brian P.P., Kai E.S., Husham S., Harmeet B., Gerald J.B., H Henry G. Radiology-pathology correlation in recovered COVID-19, demonstrating organizing pneumonia. Am J Respir Crit Care Med. 2020;202(4):598–599. - PMC - PubMed
    1. George P.M., Wells A.U., Jenkins R.G. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815. - PMC - PubMed
    1. George P.M., Barratt S.L., Condliffe R., Desai S.R., Devaraj A., Forrest I. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020 thoraxjnl-2020-215314. - PubMed